USPSTF Drops Opposition To Prostate Screening, Remains Skeptical
This article was originally published in The Gray Sheet
Executive Summary
The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated
You may also be interested in...
PSA testing
Study published in May 28 New England Journal of Medicine concludes that isolated rises in prostate-specific antigen levels should be confirmed with a follow-up test before recommending prostate biopsy. James Eastham, MD, et al., Polyp Prevention Trial Study, note that the protocol "may reduce the number of unnecessary procedures markedly." While PSA testing combined with digital rectal exam often is used for early cancer detection, the U.S. Preventive Services Task Force does not endorse the procedure (1"The Gray Sheet" Dec. 9, 2002, p. 14)...
PSA testing
Study published in May 28 New England Journal of Medicine concludes that isolated rises in prostate-specific antigen levels should be confirmed with a follow-up test before recommending prostate biopsy. James Eastham, MD, et al., Polyp Prevention Trial Study, note that the protocol "may reduce the number of unnecessary procedures markedly." While PSA testing combined with digital rectal exam often is used for early cancer detection, the U.S. Preventive Services Task Force does not endorse the procedure (1"The Gray Sheet" Dec. 9, 2002, p. 14)...
Cancer Test Trials: EU Screening Plan Envisions Proxy Endpoint Recognition
The European Commission is considering adding further diagnostic cancer screens to the testing it supports in a recently announced call for member states to establish early detection programs